NR0B2 and metabolic disease: The strong up-regulation of Fxr target gene Shp in the middle part of the small intestine might also be involved in development of these metabolic diseases, as previous null mice studies showed that mice lacking Shp are resistant to dietary fat-induced obesity and insulin resistance [36].